Fagron was founded in Rotterdam (the Netherlands) in 1990. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron obtained market leadership in pharmaceutical compounding in the Netherlands in just 7 years. Fagron’s successful strategy is focused on optimizing and innovating customized pharmaceutical care while widening therapeutic options for prescribers worldwide and improving patients’ quality of life. Its unique business model and the investments in innovation and product development resulted in the fact that Fagron is currently leading in pharmaceutical compounding and is active in 34 countries in Europe, the Americas, the Middle East, Africa, Asia and the Pacific. Fagron products and innovations are sold to over 200,000 customers in over 60 countries around the world.
Fagron Specialty Pharma Services: customized medication that is prepared in Fagron’s sterile, nuclear and non-sterile compounding facilities in Europe, North America, South America and South Africa.
Fagron Trademarks: innovative concepts, vehicles and formulations for pharmaceutical compounding that are developed by Fagron's R&D team, often in close cooperation with prescribers, pharmacies and universities.
Fagron Essentials: pharmaceutical raw materials, equipment and supplies that pharmacists need in order to be able to prepare medication in the pharmacy.